Evidence map›Paper›PMID 41974889›Full record

ArticleExperimental & molecular medicine2026

Targeted long-read sequencing for high-resolution repeat profiling in myotonic dystrophy type 1.

Yoojung Han, Ja-Hyun Jang, Hyeshik Chang

Abstract read
In one paragraph

Article in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yoojung HanCenter for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0001-4630-1322
Ja-Hyun JangDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. jahyun.jang@samsung.com.
Hyeshik ChangCenter for RNA Research, Institute for Basic Science, Seoul, Republic of Korea. hyeshik@snu.ac.kr.ORCID http://orcid.org/0000-0002-9812-8015

Funding

National Research Foundation of Korea (NRF) 2021R1F1A1046537National Research Foundation of Korea (NRF) RS-2024-00352005
6 · The paper itself

Abstract

Tandem repeat expansion disorders can be difficult to diagnose when expansions exceed 200 repeats, as standard methods (for example, Southern blot and modified PCR) often fail. We present a Cas9-targeted nanopore sequencing workflow and an automated analysis pipeline, RepeatLab, for accurate repeat-length estimation, structure assessment, and high-resolution methylation profiling. Validated on 13 myotonic dystrophy type 1 samples, 4 healthy controls, and 4 cell lines, this approach demonstrates improved sensitivity and accuracy for large expansions. Key refinements include an alternative basecalling strategy for extended repeats and a repeat-length calling algorithm that remains robust at lower sequencing throughput. The platform also automatically reports methylation near the DMPK repeat region, including five CpG site groups that could inform more nuanced clinical evaluations. This integrated workflow offers a rapid, cost-effective diagnostic solution with a turnaround time under 24 h and costs comparable to standard assays. Its compatibility with readily available computational resources enhances accessibility and scalability.

Indexed as

High-Throughput Nucleotide SequencingMyotonic DystrophyAlgorithmsCell LineDNA MethylationHumansMyotonin-Protein KinaseNanopore SequencingSequence Analysis, DNAMyotonin-Protein Kinase

Identifiers

PMID41974889
PMCPMC13144457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.